Evaluation of Endocan and Tumor Necrosis Factor-alpha as Inflammatory Biomarkers in Type 2 Diabetes and Periodontal Disease.
Purpose: Type 2 diabetes mellitus (type 2 DM) and periodontitis encompass vascular endothelial changes. Endocan, a marker of endothelial dysfunction, has not been previously evaluated in diabetic patients with periodontal disease. This study was designed ..... Read More